BioNTech Faces Tumultuous Transformation with Eye Toward Pioneering Cancer Therapies
BioNTech is shifting focus from COVID-19 vaccines to cancer therapy innovation using mRNA technology. The company faces financial challenges with a decline in earnings and revenue, indicating a tough transition…